Hubungan Antara Kadar Leukosit, Monosit, Dan Procalcitonin Dengan Risiko Terjadi Infeksi Pada Stroke Fase Akut Dan Outcome Fungsional

Loading.... (view fulltext now)

Loading....

Loading....

Loading....

Loading....

Teks penuh

(1)

DAFTAR PUSTAKA

Adeoye, O., Walsh, K., Woo, J.G., Haverbusch, M., Moomaw, C.J.,

Broderick, J.P., et al. 2014. Peripheral Monocyte Count is

Associated with Case-Fatality after Intracerebral Hemorrhage.

Journal of Stroke and Cerebrovascular Disease. 23(2):107-111.

Agnihotri, S., Czap, A., Staff, I., Fortunato, G., and McCullough, L.D.

2011. Periferal Leukocyte Counts and Outcomes after Intracerebral

Hemorrhage. Journal of Neuroinflammation. 8:160.

Alchuriyah, S., dan Wahjuni, C.U. 2016. Faktor Risiko Kejadian Stroke

Usia Muda Pada Pasien Rumah Sakit Brawijaya Surabaya. Jurnal

Berkala Epidemiologi. 4(1):62-73.

Amantea, D., Nappi, G., Bernardi, G., Bagetta, G., and Corasaniti, M.T.

2008. Minireview: Post-ischemic brain damage: pathophysiology

and role of inflammatory mediators. The FEBS Journal. 276:13-26.

Baratawidjaja, K.G., dan Rengganis, I. 2009. Imunologi Dasar. Balai

Penerbit FK UI. Jakarta.

Boehme, A.K., Kumar, A.D., Lyerly, M.J., Gillette, M.A., Siegler, J.E.,

Albright, K.C., et al. 2014. Persistent Leukocytosis-Is this a

Persistent Problem for Patients with Acute Ischemic Stroke?.

Journal of Stroke and Cerebrovascular Diseases.

(2)

Buck, B.H., Lieberkind, D.S., Saver, J.F., Bang, Y., Yun, S.W., Starman,

S., et al. 2008. Early Neutrophilia is Associated With Volume of

Ischemic Tissue in Acute Stroke. Stroke AHA.39:355-360.

Burhanudin, M., Wahiduddin., and Jumriani. 2013. Faktor Risiko Kejadian

Stroke Pada Dewasa Awal (18-40 tahun) di Kota Makasar Tahun

2010-2012. Di unduh dari http://repository.unhas.ac.id.

CDC/NHSN Protocol Clarifications. 2013. CDC/NHSN Surveillance

Definitions for Specific Types of Infections. Available:

http://www.cdc.gov/nhsn/pdfs/pscmanual/protocol-clarification.pdf

Chamorro, A., Amaro, S., Vargas, M., Obach, V., Cervera, A., Torres, F.,

et al. 2006. Interleukin 10, Monocytes and Increased risk of early

infection in ischemic stroke. J Neurol Neurosurg Psychiatry.

77:1279-81.

Chamorro, A., Meisel, S., Planas, A.M., Urra, X., Van De Beek, D., and

Veltkamp, R. 2012. The Immunology of Acute Stroke. Nature

Review Neurology. 8:401-410.

Chiba, T., and Umegaki, K. 2013. Pivotal Roles of Monocytes/

Macrophages in Stroke. Hindawi Publishing Corporation. p.1-10.

Christ-Crain, M., and Müller, B. 2005. Procalcitonin in bacterial infections -

hype, hope, more or less?. Swiss Med Wkly.135:451-460.

Deng, W.J., Shen, R.L., Li, M., and Teng, J.F. 2015. Relationship Between

(3)

Dirnagl, U., Ladecola, C., and Moskowitz, M.A., 1999. Pathobiology of

ischemic stroke: an integrated view. Trends Neurosci. 22:391-397.

Dirnagl, U., Klehmet, J., Braun, J.S., Harms, H., Meisel, C., Ziemssen, T.,

et al. 2007. Stroke-Induced Immunodepression: Experimental

Evidance and Clinical Relevance. American Heart Association.

38:770-773.

Emsley, H.C.A., and Tyrrell, P.J. 2002. Inflammation and Infection in

Clinical Stroke. Journal of Cerebral Blood Flow and Metabolism.

22:1399-1419.

Farida dan Amelia. 2009. Mengantisipasi Stroke. Jogjakarta. Penerbit

Buku Biru.

Fluri, F., Morgenthaler, N.G., Mueller, B., Christ-Crain, M., and Katan, M.

2012. Copeptin, Procalcitonin and Routine Inflammatory

Markers-Predictors of Infection after Stroke. Plos One; 7(10):48309l:1-7.

Fuentes, B., Castillo, J., Jose, B.S., Leira, R., Serena, J., Vivancos, J.,et

al. 2009. The Prognostic Value of Capillary Glucose Levels in

Acute Stroke. Stroke. 40:562-568.

Furlan, J.C., Vergouwen, M.D.I., Fang, J., and Silver, F.L. 2013. White

blood cell count is an independent predictor of outcomes after acute

ischaemic stroke. European Journal of Neurology. 10:1-8.

Ganong W.F. 2003. Review of Medical Physiology. 21th edition. Lange

(4)

Goldstein, L.B., Adams, R., Alberts, M,J., Alberts, M.J., Appel, L.J., Brass,

L.M., et al. 2006. Primary Prevention of Ischemic stroke: A Guidline

from the American Heart Association/American Stroke Association

Stroke Council. Stroke. 37:1583-1633.

Gu, L., Jian, Z., Stary, C., and Xiong, X. 2015. T Cells and Cerebral

Ischemic Stroke. Neurochem Res. 40:1786-1791

Hallenbeck, J., Zoppo, G., Jacobs, T., Hakim, A., Goldman, S., Utz, U., et

al. 2006. Immunomodulation Strategies for Preventing Vascular

Disease the Brain and Heart Workshop Summary. Stroke. 37(12):

3035-3042.

Harms, H., Halle, E., and Andreas, M. 2010. Post-Stroke Infections –

Diagnosis, Prediction, Prevention and Treatment to Improve Patient

Outcomes. European Neurological Review;5(1):39–43.

Hatzistilianou, M. 2010. Diagnostic and Prognostic Role of Procalcitonin in

Infections. The Scientific World Journal.10:1941-1946.

Hertog, H.M., Rossum, J.A., Worp, H.B., Gemert, H.M., Jonge, R.,

Koudstaal, P.J., et al. 2009. C-reactive protein in the very early

phase of acute ischemic stroke: association with poor outcome and

death. J Neurol. 256:2003-2008.

Iranmanesh, F., Zia-Sheykholeslami, N., Vakilian, A., and Sayadi, A.,

2012. Relationship between White Blood Cell Count and Mortality in

(5)

Jood, K., Redfors, P., Rosengren, A., Blomstrand, C., and Jern, C. 2009.

Self-perceived psychological stress and ischemic stroke: a

case-control study. BMC Medicine. 7:53-60.

Kaito, M., Araya, S.I., Gondo, Y., Fujita, M., Minato, N., Nakanishi, M., et al

2013. Relevance of Distinct Monocyte Subsets to Clinical

Course of Ischemic Stroke Patients. Journal Pone. 8(8):69409.

Kammersgaard, L.P., Jorgensen, H.S., Nakayama, H., Reith, J.,

Biomarkers of Sepsis in Critical Care. Journal of Antimicrobial

Chemotherapy. 66 (2): Ii33-Ii40

Kumar, A.D., Boehme, A.K., Siegler, J.E., Gillette, M., Albright, K.C., and

Martin-Schild, S. 2013. Leukocytosis in Patients with Neurologic

Deterioration after Acute Ischemic Stroke is Associated with Poor

Outcomes. J Stroke Cerebrovasc Dis. 22(7):e111-e117.

Kwan, J., Jenkinson, D., Vassallo, M., Englyst, N., and Perry, V.H. 2008.

Systemic infection after acute stroke. Aging Health. 4(1):1-10.

Meisel, A., Meisel, C., Harms, H., Hartman, O., and Ulm, L. 2012.

(6)

Immune and Stress Markers. Cerebrovascular Diseases.

33:580-588.

Misbach, J. 2009. Stroke : Aspek Diagnostik, Patofisiologi, Manajemen.

Balai penerbit FK-UI. Jakarta.

Misbach, J., Lamsudin, R., Aliah, A., Basyiruddin., Suroto., Alfa, AY., dkk.

2011. Guidline Stroke. Pokdi Stroke PERDOSSI. Diterbitkan oleh:

Perhimpunan Dokter Spesialis Saraf Indonesia (PERDOSSI).

Jakarta.p.1.

Miyakis, S., Georgakopoulos, P., Kiagia, M., Pefanis, A., and

Mountokalakis, T.D. 2004. Serial serum procalcitonin changes in

the prognosis of acute stroke. Clinica Chimica Acta. 237-239.

Miyakis, S., Bergmann, A., Hartmann, O., Hein, F., and Muller, B. 2012.

Procalcitonin for The Diagnosis of Bacterial Infections and

Guidance of Antibiotic Treatment in Patients with Acute Stroke of

Transient Ischemic Attack. United States Patent.1-11.

Nardi, K., Milia, P., Eusebi, P., Paciaroni, M., Caso, V., and Agnelli, G.

2012. Admission Leukocytosis in Acute Cerebral Ischemia:

Influence on Early Outcome. Journal of Stroke and Cerebrovascular

Disease. 21(8):819-824.

Nikanfar, M., Shaafi, S., Hashemilar, M., Oskouii, D.S., and Goldust, M.

2012. Evalluating Role of Leukocytosis and High Sedimentation

(7)

Painthakar, M.M., and Dabhi, R.D. 2003. Functional Recovery in Ischemic

Stroke. Neurol India. 51:414-6.

Peng, Y., Wang, D., Zhang, J., Xue, X., Wang,Z., Tomg, W., et al. 2011.

Relationship between white blood cell count at admission and short

term outcome in patients with acute cerebral infarction. Clin Invest

Med. 34(4):249-254.

Popovic, N.MD., Stefanovic-Budimkic, M., Mitrovic, N.MD., Urosevic,

A.MD., Milosevic, B,MD., Pelemis, M.MD., et al. 2013. The

Frequency of Poststroke Infections and Their Impact on Early

Stroke Outcome. Journal of Stroke and Cerebrovascular Diseases.

4(22):pp424-429.

Purba, J.S., dan Misbach, J. 2011. Biomolekuler Stroke. Dikutip dari:

Stroke : Aspek Diagnostik, Patofisiologi, Manajemen. Balai

Penerbit FK - UI. Jakarta. p:41-52.

Sacco, R.L., Kasner, S.E., Broderick, J.P., Caplan, L.R., Culebras, A.,

Elkind, M.S.V., et al. 2013. An Udate Defenition of Stroke for the

21st Century: A Statement for Healthcare Professionals From the

American Heart Association/American Stroke Association. Stroke.

44:2064-2089.

Sacher, R.A., dan McPherson, R.A. 2005. Tinjauan klinis hasil

pemeriksaan laboratorium. Alih bahasa: BU. Penerbit D. Wulandari.

(8)

Sen, S., Hinderliter A., Sen, P.K., Simmons, J., LeGrys, V.A., Beck J., et

al. 2007. Association of Leukocyte Count With Progression of Aortic

Atheroma in Stroke/transient Ischemic Attack Patients. American

Heart Association.38:2900-2905

Sherwood, L. 2012. Fundamentals of Human Physiology, Fourth Edition.

Brooks/Cole 20 Davis Drive Belmont; USA.

Sjahrir, H. 2003. Stroke Iskemik. Yandira Agung. Medan.

Su, L., Han, B., Liu, C., Liang, L., Jiang, Z., Deng, J., et al. 2012. Value of

soluble TREM-1, procalcitonin, and C-reactive protein serum levels

as biomarkers for detecting bacteremia among sepsis patients with

new fever in intensive care units: a prospective cohort study. BMC

Infectious Disease.12(157):1-10

Urra, X., Villamor, N., Amaro, S., Choco, M.G., Obach, V., Oleaga, L., et

al. 2009. Monocyte subtype predict clinical course and prognosis in

human stroke. Journal of Cerebral Blood Flow and Metabolism.

29:994-1002.

Vogelgesang, A., Grunwald, U., Langner, S., Jack, R., Broker, B.M., et al.

2008. Analysis of Lymphocyte Subsets in Patients With Stroke and

Their Influence on Infection After Stroke. Stroke. 39: 237-241

Wang, P.Y., Kao, C.H., Mui, M.Y., and Wang, S.J. 1993. Leukocyte Infiltration in Acute Hemisphere Stroke. Stroke. 24:236-240.

(9)

Factors, Biomarkers, and Outcome. Stroke Research and

Treatment. p.1-9.

Westendorp, W.F., Nederkoom, P.J., Vermeij, J.D., Dijkgraaf, M.G., and

Beek, D. 2011. Post-stroke infection: A systematic review and

meta-analysis. BMC Neurology. 11:110.

Whiteley, W., Jackson, C., Lewis, S., Lowe, G., Rumley, A., Sandercock,

P., Wardlaw, J., et al. 2009. Inflammatory Markers and Poor

Outcome after Stroke: A Prospective Cohort Study and Systematic

Review of Interleukin-6. Plos Medicine. 6:1-10.

Zeller, J.A., Lenz, A., Eschenfelder, C.C., Zunker, P., and Deuschi,G.

2005. Platelet Activation in Acute Stroke With and Without

Preceding Infection. Arterioscler Thromb Vasc Biol

Figur

Memperbarui...

Referensi

Memperbarui...